THE CLINICAL STUDIES OF CEFOPERAZONE (T-1551) IN OTO-RHINO-LARYNGOLOGICAL FIELD

DOI Web Site
  • AWATAGUCHI SHOGO
    Oto-Rhino-Laryngological Clinic, Central, Prefectural Hospital of Aomori
  • MIYANO KAZUO
    Oto-Rhino-Laryngological Clinic, Central, Prefectural Hospital of Aomori
  • MARUYAMA KOYO
    Oto-Rhino-Laryngological Clinic, Central, Prefectural Hospital of Aomori
  • KASAHARA MASAAKI
    Department of Oto-Rhino-Laryngology, Hirosaki University, School of Medicine

Bibliographic Information

Other Title
  • Cefoperazone (T-1551) 投与例の臨床的研究
  • Cefoperazone T 1551 トウヨレイ ノ リンショウテキ ケンキ
  • 耳鼻咽喉科領域の感染症

Search this article

Description

Cefoperazone (CPZ, T-1551) was tested clinically in 15 cases (7 with sinal, tonsillar or laryngeal acute infections, 6 with Pseudomonas aeruginosa infections following total resection of sinal, laryngeal or glossal cancers, one with reticulosarcoma of nose infected by Staphylococcus aureus and one with rhinitis gangrenosa infected by Klebsiella) by the intravenous injection or intravenous drip infusion of 0.5-4 g of CPZ daily for a short or long duration.<BR>As a result, the responses were “excellent” in 4 cases, “good” in 9 and “poor” in 2. It was concluded that the effective results (good to excellent) was obtained in a large number as 13 out of 15 (86%) by the intravenous administration of CPZ. No side effect was found in all 15 cases.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 28 (Supplement6), 853-858, 1980

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top